Company InDex Pharmaceuticals Holding AB Nasdaq Stockholm
Equities
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- SEK | - |
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals for Immunological Diseases
100.0
%
| 0 | nan % | 98 | 100.0 % | - |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| - | - | 98 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 01/23/01 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 01/17/01 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Eva Arlander
PRN | Corporate Officer/Principal | 60 | 02/22/02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 01/16/01 |
Director/Board Member | 68 | 01/11/01 | |
Chairman | 72 | 01/11/01 | |
Karin Bernadotte
BRD | Director/Board Member | 61 | 01/22/01 |
Marlene Forsell
BRD | Director/Board Member | 48 | 01/20/01 |
Director/Board Member | 56 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 532,687,650 | 332,794,895 ( 62.47 %) | 0 | 62.47 % |
Company contact information
InDex Pharmaceuticals Holding AB
Berzelius vaeg 13
171 65, Solna
+46 8 12 20 38 50
http://www.indexpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+32.36% | 694B | |
+30.77% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.62% | 239B | |
+10.05% | 209B | |
-3.03% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- INDEX Stock
- Stock
- Company InDex Pharmaceuticals Holding AB